| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 184,721 | 118,018 | 66,168 | | Cost of Revenue | 64,766 | 40,984 | 23,872 | | | Gross Profit | 119,955 | 77,034 | 42,296 | | | Operating Expenses | | Research Development | 46,345 | 34,071 | 24,519 | | Selling General and Administrative | 75,632 | 54,959 | 34,200 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (2,022) | (11,996) | (16,423) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,465 | 3,016 | 1,779 | | Earnings Before Interest And Taxes | (557) | (8,980) | (14,644) | | Interest Expense | 185 | 958 | 769 | | Income Before Tax | (742) | (9,938) | (15,413) | | Income Tax Expense | 217 | 158 | 72 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (959) | (10,096) | (15,485) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (959) | (10,096) | (15,485) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($959) | ($10,096) | ($15,485) |
|
0.29% Nasdaq 
Income Statement
